Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Progesterone and Vitamin D3 in Breast Cancer
NCT01608451Phase 3Terminated
- Sponsor
- Tata Memorial Hospital
- Start
- Sep 2007
- Primary completion
- Aug 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxyprogesterone caproate, vitamin d in breast cancer, sponsored by Tata Memorial Hospital. Started Sep 2007; status: terminated.
02
Drugs
hydroxyprogesterone caproatevitamin d
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01608451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01608451.